Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort.
Saugues S, Lambert C, Daguenet E, Roth-Guepin G, Huguet F, Cony-Makhoul P, Ansah HJ, Escoffre-Barbe M, Turhan A, Rousselot P, Tchirkov A, Hamroun D, Hermet E, Pereira B, Berger MG. Saugues S, et al. Among authors: daguenet e. Haematologica. 2024 May 2. doi: 10.3324/haematol.2023.284860. Online ahead of print. Haematologica. 2024. PMID: 38695126 Free article.
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment.
Fouillet L, Daguenet E, Tavernier E, Ghesquières H, Bachy E, Sesques P, Tournilhac O, Bay JO, Michallet AS, Sapet M, Chalayer E, Guyotat D, Tinquaut F, Cornillon J. Fouillet L, et al. Among authors: daguenet e. Leuk Lymphoma. 2024 Feb;65(2):270-274. doi: 10.1080/10428194.2023.2281270. Epub 2024 Jan 24. Leuk Lymphoma. 2024. PMID: 37966973 No abstract available.
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
Garderet L, Ouldjeriouat H, Bekadja MA, Daguenet E, Bigot N, Vincent L, Roos-Weil D, Vignon M, Ikhlef S, Abraham J, Escoffre-Barbe M, Lioure B, Nacer RA, Lafon I, Mariette C, Karlin L, Morel P, Gilis L, Le Ray E, Blouet A, Nguyen Quoc S, Boffa JJ, Ronco P, Lambert J, Cornillon J. Garderet L, et al. Among authors: daguenet e. Br J Haematol. 2024 Apr;204(4):1450-1458. doi: 10.1111/bjh.19163. Epub 2023 Nov 12. Br J Haematol. 2024. PMID: 37953476
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Rey G, Daguenet E, Bonjean P, Devillier R, Fegueux N, Forcade E, Srour M, Chevallier P, Robin M, Suarez F, Micol JB, Labussière-Wallet H, Bilger K, Daguindau E, Bay JO, Fayard A, Bulabois CE, Nguyen-Quoc S, Genthon A, Orvain C, Turlure P, Loschi M, Poiré X, Guillerm G, Beguin Y, Maillard N, Mear JB, Chalayer E, Cornillon J, Tavernier E. Rey G, et al. Among authors: daguenet e. Bone Marrow Transplant. 2023 Dec;58(12):1331-1338. doi: 10.1038/s41409-023-02082-5. Epub 2023 Aug 31. Bone Marrow Transplant. 2023. PMID: 37653054 Free article.
Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome.
Faurel A, Heiblig M, Kosmider O, Cornillon J, Boudou L, Guyotat D, Martignoles JA, Jamilloux Y, Noyel P, Daguenet E, Faure AC, Sujobert P, Flandrin-Gresta P. Faurel A, et al. Among authors: daguenet e. Hemasphere. 2023 Mar 24;7(4):e868. doi: 10.1097/HS9.0000000000000868. eCollection 2023 Apr. Hemasphere. 2023. PMID: 36999004 Free PMC article. No abstract available.
53 results